Bernard J Cassidy
CIK 1398322 · EVP & General Counsel · last filed 2025-03-10
Bernard J Cassidy is an EVP & General Counsel who has filed 57 SEC Form 4 insider transactions across 3 companies since 2008. The most recent filing, for SANA, was dated Mar 10, 2025. Across all open-market trades the lifetime net is −$5.3M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $302.8K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$302.8K
3
57
-$5.27M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SANA | EVP & General Counsel | 112,990 | $2.68 | $302.8K | $0 | 4 | 2025-03-10 |
| Juno Therapeutics, Inc. (JUNO) Delisted | General Counsel & Secretary | 79,825 | — | — | -$4.52M | 22 | 2018-03-07 |
| TESSERA TECHNOLOGIES INC (TSRA) Delisted | EVP & GC, TIPC President | 45,736 | — | — | -$751.0K | 25 | 2013-03-07 |
Recent Filings
57 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-03-10 | SANA | Mixed | +8,208 | -$7.3K | EDGAR |
| 2024-03-08 | SANA | Grant (A) | — | $0 | EDGAR |
| 2023-03-03 | SANA | Grant (A) | — | $0 | EDGAR |
| 2022-09-16 | SANA | Grant (A) | — | $0 | EDGAR |
| 2018-03-07 | Juno Therapeutics, Inc. (JUNO) Delisted | Mixed | −112,252 | -$2.82M | EDGAR |
| 2018-02-09 | Juno Therapeutics, Inc. (JUNO) Delisted | Mixed | −28,162 | -$130.6K | EDGAR |
| 2018-02-02 | Juno Therapeutics, Inc. (JUNO) Delisted | Grant (A) | +25,639 | $0 | EDGAR |
| 2017-10-20 | Juno Therapeutics, Inc. (JUNO) Delisted | Grant (A) | +35,893 | $0 | EDGAR |
| 2017-09-14 | Juno Therapeutics, Inc. (JUNO) Delisted | Sell (S) | −28,000 | -$1.26M | EDGAR |
| 2017-02-09 | Juno Therapeutics, Inc. (JUNO) Delisted | Grant (A) | +24,390 | $0 | EDGAR |